Legal & General Group Plc - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 76 filers reported holding IMMUNE DESIGN CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$34,000
+325.0%
5,7950.0%0.00%
Q4 2018$8,000
-60.0%
5,7950.0%0.00%
Q3 2018$20,000
-23.1%
5,7950.0%0.00%
Q2 2018$26,000
+36.8%
5,7950.0%0.00%
Q1 2018$19,000
-17.4%
5,7950.0%0.00%
Q4 2017$23,000
-36.1%
5,795
+64.8%
0.00%
Q3 2017$36,000
+63.6%
3,517
+59.4%
0.00%
Q2 2017$22,000
+46.7%
2,2060.0%0.00%
Q1 2017$15,000
+15.4%
2,2060.0%0.00%
Q4 2016$13,0002,2060.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2017
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$97,072,000100.00%
ProQuest Associates IV LLC 2,695,757$82,975,00042.05%
Cormorant Asset Management, LP 140,000$4,309,0000.66%
HAMILTON LANE ADVISORS LLC 42,812$1,318,0000.50%
Spark Investment Management LLC 16,300$498,0000.08%
RS INVESTMENT MANAGEMENT CO LLC 299,102$9,206,0000.08%
Focused Wealth Management, Inc 1,634$50,0000.04%
SECTORAL ASSET MANAGEMENT INC 21,181$652,0000.03%
Numeric Investors LLC 37,012$1,139,0000.02%
FRANKLIN RESOURCES INC 738,026$22,716,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders